EcoDrugPlus

Cyclin-Dependent Kinase 7

Ensembl ID : ENSMAUG00000014063
Gene Symbol: CDK7
1 Cross references
213 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSMAUG00000016351
Gene Symbol: CYSLTR1
3 Cross references
177 Possible Orthologues:

Cystic Fibrosis Transmembrane Conductance Regulator

Ensembl ID : ENSMAUG00000013946
Gene Symbol: CFTR
1 Cross references
216 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSMAUG00000017832
Gene Symbol: CDA
1 Cross references
224 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSMAUG00000002930
Gene Symbol: LOC101836237
4 Cross references
207 Possible Orthologues:

Cytochrome P450 3a31-Like

Ensembl ID : ENSMAUG00000013270
Gene Symbol: LOC101836914
2 Cross references
637 Possible Orthologues:

Cytochrome P450 3a9

Ensembl ID : ENSMAUG00000009938
Gene Symbol: LOC101839056
4 Cross references
627 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSMAUG00000004739
Gene Symbol: DGAT1
4 Cross references
260 Possible Orthologues:

Dihydrofolate Reductase

Ensembl ID : ENSMAUG00000020170
Gene Symbol: DHFR
3 Cross references
351 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSMAUG00000005725
Gene Symbol: DHODH
4 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSMAUG00000016874
Gene Symbol: DPYD
3 Cross references
220 Possible Orthologues:

Dipeptidylpeptidase 4

Ensembl ID : ENSMAUG00000002786
Gene Symbol: DPP4
1 Cross references
282 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).